BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11139950)

  • 1. Atrial pacing in the prevention of paroxysmal atrial fibrillation: first results of a new combined algorithm.
    Israel CW; Lawo T; Lemke B; Grönefeld G; Hohnloser SH
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1888-90. PubMed ID: 11139950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
    Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study.
    Nigro G; Russo V; Rago A; Antonio Papa A; Palladino A; Politano L
    Acta Myol; 2012 Oct; 31(2):139-43. PubMed ID: 23097606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of right atrial pacing preference in prevention of paroxysmal atrial fibrillation: Atrial Pacing Preference study (APP study).
    Ogawa H; Ishikawa T; Matsushita K; Matsumoto K; Ishigami T; Sugano T; Uchino K; Umemura S; Sumita S; Kimura K; Nakagawa T; Shimizu M; Nishikawa H; Kasai A; Kioka Y
    Circ J; 2008 May; 72(5):700-4. PubMed ID: 18441446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.
    Pürerfellner H; Ruiter JH; Widdershoven JW; Van Gelder IC; Urban L; Kirchhof CJ; Havlicek A; Kornet L;
    Heart Rhythm; 2006 Oct; 3(10):1164-71. PubMed ID: 17018345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.
    Russo V; Rago A; Politano L; Della Cioppa N; Russo MG; Golino P; Calabrò R; Nigro G
    Europace; 2012 Apr; 14(4):486-9. PubMed ID: 22135319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
    Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
    Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V
    Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation.
    Kale M; Bennett DH
    Europace; 2003 Apr; 5(2):123-31. PubMed ID: 12633635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.
    Camm AJ; Sulke N; Edvardsson N; Ritter P; Albers BA; Ruiter JH; Lewalter T; Capucci PA; Hoffmann E;
    Europace; 2007 Dec; 9(12):1110-8. PubMed ID: 18042619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry.
    Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
    Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
    Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of concomitant drug therapy on the efficacy of atrial overdrive stimulation for prevention of atrial tachyarrhythmias.
    Konz KH; Danilovic D; Brachmann J; Attuel P; el Allaf D; John C; Malinowski K; Le Blanc U; Szendey I; Schibgilla V; Motzke T
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):272-7. PubMed ID: 12687827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.
    Adler SW; Wolpert C; Warman EN; Musley SK; Koehler JL; Euler DE
    Circulation; 2001 Aug; 104(8):887-92. PubMed ID: 11514374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.